Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Heterologous Immunization with Improved HIV-1 Subtype C Vaccines Elicit Autologous Tier 2 Neutralizing Antibodies with Rapid Viral Replication Control After SHIV Challenge

Viruses(2025)10.3390/v17020277Source: DataRank Database

Heterologous Immunization with Improved HIV-1 Subtype C Vaccines Elicit Autologous Tier 2 Neutralizing Antibodies with Rapid Viral Replication Control After SHIV Challenge is a research paper published in Viruses (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

Linked data & code

gen

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 0.00)OA: goldTopics (45)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Rosamund Chapman ORCID,Alana Keyser,Craig H. Adams,Kealan Benn,Michiel T. van Diepen ORCID

Live enrichment

PubMed:40007032 PMC:PMC11861162 OpenAlex:https://openalex.org/W4407622761

South African Medical Research Council

Grant: 98341

FWCI

0.00

Citation Percentile

0.0%

goldLicense: cc-by

journalhttps://www.mdpi.com/1999-4915/17/2/277/pdf?version=1739791671

publisherhttps://www.mdpi.com/1999-4915/17/2/277/pdf?version=1739791671

publisherhttps://www.mdpi.com/1999-4915/17/2/277/pdf

journalhttps://doi.org/10.3390/v17020277

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40007032

Fields of Study

HIV Research and TreatmentImmune Cell Function and InteractionT-cell and B-cell Immunology

MeSH Terms

AnimalsHumansImmunization, SecondaryMacacaVirus ReplicationSimian Immunodeficiency VirusHIV AntibodiesHIV-1HIV InfectionsSimian Acquired Immunodeficiency SyndromeAIDS VaccinesSAIDS VaccinesVaccines, DNAenv Gene Products, Human Immunodeficiency VirusAntibodies, NeutralizingHEK293 CellsSimian immunodeficiency virus

Keywords

VirologyVaccinationELISPOTAntibodyHeterologousBiologyDNA vaccinationHIV vaccineNeutralizing antibodyAntigenImmunologyAIDS VaccinesImmunizationVaccine trialVirusImmune systemT cellGeneDNA vaccineImmunogenicityNeutralizationShivChinese Rhesus MacaquesMva VaccineGp140 Env

Sustainable Development Goals

SDG 0: Good health and well-being

Heterologous Immunization with Improved HIV-1 Subtype C Vaccines Elicit Autologous Tier 2 Neutralizing Antibodies with Rapid Viral Replication Control After SHIV Challenge

FAIR Checklist

Authors (11)

Funding (1 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)